Do GPOs Play a Role in Drug Shortages? Long-Standing Allegations Disputed by The GPOs [0.03%]
集团采购组织应对药物短缺吗？集团采购组织驳斥长期存在的指控
Stephen Barlas
Stephen Barlas
What role, if any, do group purchasing organizations play in drug shortages?
Paralyzed by Mistakes - Reassess the Safety of Neuromuscular Blockers in Your Facility [0.03%]
慎用神经肌肉阻滞剂：评估您机构中的安全性
Matthew Grissinger
Matthew Grissinger
Neuromuscular blockers have been inadvertently administered to patients who were not receiving proper ventilatory assistance, causing death or permanent injuries.
Aligning Formulary Restrictions Across a Health System and Improving Access to and Clarity of Medication Restrictions [0.03%]
药典限制在医疗系统中的协调统一以及改善药物限制的获得性和清晰度
Sarah Solano,Jordan Dow,Terry Audley et al.
Sarah Solano et al.
Background: In 2013, formulary medications were aligned among the three hospitals within our health system. However, as formulary medication restrictions were not aligned, the three hospitals continued to have inconsisten...
James Smeeding,Daniel C Malone,Monica Ramchandani et al.
James Smeeding et al.
Evaluating biosimilars requires payers to go beyond cost considerations: safety and efficacy, reliability of supply and logistics, and the impact of state laws on substitution and interchangeability must all be deliberated. ...
Walter Alexander
Walter Alexander
We report on sessions on the dapagliflozin effect on cardiovascular events; angiotensin receptor-neprilysin inhibition for acute decompensated heart failure; rivaroxaban's effect on thromboembolic events with heart failure, sinus rhythm, an...
Biosimilar Roadblock Removals Seem Tailor-Made for Trump/Democrats Agreement: Development of New Biosimilar Drugs and Marketing of Few Approved Drugs Stymied [0.03%]
仿制药发展和已获批药物营销受阻 特朗普政府和民主党似乎将扫除这些障碍
Stephen Barlas
Stephen Barlas
The United States is lagging behind Europe in biosimilar use, and missing out on a wider range of medication options and huge savings in drug expenditures. What's causing the holdup?
Michele B Kaufman
Michele B Kaufman
Arikayce (amikacin liposome inhalation suspension) for Mycobacterium avium complex lung disease; Xofluza (baloxavir marboxil) for acute uncomplicated influenza; and Nuzyra (omadacycline) for community-acquired bacterial pneumonia and/or acu...